16 Gy low-voltage x-ray irradiation followed by as needed ranibizumab therapy for age-related macular degeneration: 12 month outcomes of a 'radiation-first' strategy

British Journal of Ophthalmology

Volumn 96, Issue 10, 2012, Pages 1320-1324

  Moshfeghi, Andrew A ^a   Morales Canton, Virgilio ^b   Quiroz Mercado, Hugo ^b,c   Velez Montoya, Raul ^b,c   Zavala Ayala, Alicia ^b   Shusterman, Eugene Mark ^d   Kaiser, Peter K ^e   Sanislo, Steven R ^f   Gertner, Michael ^d   Moshfeghi, Darius M ^f  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b IAP ^*  (Mexico)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d Oraya Therapeutics Inc   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB;

ADULT; AGED; ARTICLE; CILIARY DISK; CLINICAL ARTICLE; FEMALE; FOLLOW UP; FRACTIONAL ANISOTROPY; HUMAN; MALE; OPEN STUDY; OPTICAL COHERENCE TOMOGRAPHY; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA MACULA AGE RELATED DEGENERATION; RETINAL THICKNESS; SAFETY; STEREOTACTIC RADIOTHERAPY; STEREOTACTIC TREATMENT; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; VISUAL SYSTEM PARAMETERS;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; CHEMORADIOTHERAPY; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; RADIATION DOSAGE; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 84867090012     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2011-301222     Document Type: Article

References (25)

1. Stevenson MR, Hart PM, Chakravarthy U, et al. Visual functioning and quality of life in the SubFoveal Radiotherapy Study (SFRADS): SFRADS report 2. Br J Ophthalmol 2005;89:1045-51. (Pubitemid 41081422)
2. Sivagnanavel V, Evans JR, Ockrim Z, et al. Radiotherapy for neovascular age-related macular degeneration. Cochrane Database Syst Rev 2004;CD004004.
3. Prettenhofer U, Haas A, Mayer R, et al. Long-term results after external radiotherapy in age-related macular degeneration. A prospective study. Strahlenther Onkol 2004;2:91-5. (Pubitemid 38165880)
4. Marcus DM, Peskin E, Maguire M, et al. The age-related macular degeneration radiotherapy trial (AMDRT): one year results from a pilot study. Am J Ophthalmol 2004;138:818-28. (Pubitemid 39452930)
5. Churei H, Ohkubo K, Nakajo M, et al. External-beam radiation therapy for age-related macular degeneration: two years' follow-up results at a total dose of 20 Gy in 10 fractions. Radiat Med 2004;6:398-404. (Pubitemid 40144017)
6. Aisenbrey S, Lafaut BA, Reynders S, et al. Clinicopathological correlation of choroidal neovascularization after external beam radiotherapy in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2003;241:269-76. (Pubitemid 36748556)
7. Valmaggia C, Ries G, Ballinari P. Radiotherapy for subfoveal choroidal neovascularization in age-related macular degeneration: a randomized clinical trial. Am J Ophthalmol 2002;133:521-9. (Pubitemid 34258061)
8. Hart PM, Chakravarthy U, Mackenzie G, et al. Visual outcomes in the subfoveal radiotherapy study: a randomized controlled trial of teletherapy for age-related macular degeneration. Arch Ophthalmol 2002;120:1029-38. (Pubitemid 34856070)
9. Marcus DM, Sheils W, Johnson MH, et al. External beam irradiation of subfoveal choroidal neovascularization complicating age-related macular degeneration: one-year results of a prospective, double-masked, randomized clinical trial. Arch Ophthalmol 2001;119:171-80. (Pubitemid 32147923)
10. Chakravarthy U, MacKenzie G. External beam radiotherapy in exudative age-related macular degeneration: a pooled analysis of phase I data. Br J Radiol 2000;73:305-13. (Pubitemid 30192804)
11. Char DH, Irvine AI, Posner MD, et al. Randomized trial of radiation for age-related macular degeneration. Am J Ophthalmol 1999;127:574-8. (Pubitemid 29215769)
12. A prospective, randomized, double-masked trial on radiation therapy for neovascular age-related macular degeneration (RAD Study). Radiation therapy for age-related macular degeneration. Ophthalmology 1999;106:2239-47.
13. Finger PT, Gelman YP, Berson AM, et al. Palladium-103 plaque radiation therapy for macular degeneration: results of a 7 year study. Br J Ophthalmol 2003;87:1497-503. (Pubitemid 38010556)
14. Jaakkola A, Tommila P, Laatikainen L, et al. Grading choroidal neovascular membrane regression after strontium plaque radiotherapy; masked subjective evaluation vs planimetry. Eur J Ophthalmol 2001;11:269-76. (Pubitemid 33042279)
15. Jaakkola A, Heikkonen J, Tarkkanen A, et al. Visual function after strontium-90 plaque irradiation in patients with age-related subfoveal choroidal neovascularization. Acta Ophthalmol Scand 1999;1:57-61. (Pubitemid 29057489)
16. Finger PT, Berson A, Ng T, Szechter A. Ophthalmic plaque radiotherapy for age-related macular degeneration associated with subretinal neovascularization. Am J Ophthalmol 1999;127:170-7. (Pubitemid 29072557)
17. Jaakkola A, Heikkonen J, Tommila P, et al. Strontium plaque irradiation of subfoveal neovascular membranes in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 1998;1:24-30. (Pubitemid 28080567)
18. Emery RS, Szechter A. Seed localization in eye plaque brachytherapy. Med Phys 1998;25:1491-2. (Pubitemid 28376363)
19. Avila MP, Farah ME, Santos A, et al. Twelve-month short-term safety and visual-acuity results from a multicentre prospective study of epiretinal strontium-90 brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularisation secondary to age-related macular degeneration. Br J Ophthalmol 2009;93:305-9.
20. Avila MP, Farah ME, Santos A, et al. Twelve-month safety and visual acuity results from a feasibility study of intraocular, epiretinal radiation therapy for the treatment of subfoveal CNV secondary to AMD. Retina 2009;29:157-69.
21. Moshfeghi AA, Morales-Canton V, Quiroz-Mercado H, et al. 16-Gy low-voltage x-ray irradiation followed by as-needed ranibizumab therapy for AMD: 6-month outcomes of a "radiation-rirst" strategy. Ophthalmic Surg Lasers Imaging 2011;42:1-8.
22. Moshfeghi DM, Kaiser PK, Gertner M. Stereotactic low-voltage x-ray irradiation for age-related macular degeneration. Br J Ophthalmol 2010;95:185-8.
23. Morales-Canton V, Quiroz-Mercado H, Velez-Montoya R, et al. 16-Gy low-voltage x-ray irradiation with ranibizumab therapy for AMD: 6-month safety and functional outcomes. Ophthalmic Surg Lasers Imaging 2011;42:1-6.
24. CATT Research Group. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 2011;364:1897-908.
25. Morales-Canton V, Quiroz-Mercado H, Velez-Montoya R, et al. 24-Gy low-voltage x-ray irradiation with ranibizumab therapy for neovascular AMD: 6-month safety and functional outcomes. Ophthalmic Surg Lasers Imaging 2012;43:20-4.